Webinar: The FDA’s perspective on Contamination Control Strategy (CCS)

Webinar: The FDA’s perspective on Contamination Control Strategy (CCS)
Wednesday 15th April 2026 2pm – 3pm (BST)Member Fee £80 (Join Now) / Non-Member Fee £110

Since the publication of the current Annex 1 in 2022, there is much more awareness and focus for both companies and Regulatory Bodies to have an effective Contamination Control Strategy (CCS) in implemented. It was initially seen as a “European” requirement, and not much of an area the US FDA would focus on. However, is that true? This webinar will discuss the FDA’s perspective on CCS and highlights some important documents and experiences that can help companies achieving compliance with the expectations from the FDA.

This webinar will cover:

• Sterility Assurance
• Contamination Control Strategy
• Sterile Manufacturing: Annex 1 vs FDA guidelines
• CCS for steriles and non-steriles

Led by: Patrick Nieuwenhuizen Managing Director, Consultant, Paradigm & Pharmig Committee Member

Please click here to download the webinar agenda and booking form